Clinical Trials in Arizona

Showing 4061-4080 of 16,770 trials

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

NCT06928337

This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.

Fertility Disorders

Fairtility350 participantsStarted May 2025

Scottsdale, Arizona, United States

COMPLETEDPhase 331 miles

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541

The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (positive reverse transcription polymerase chain reaction \[RT-PCR\] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo tablets in participants who are household contacts of an individual with symptomatic COVID-19.

SARS-CoV-2 Infection

Shionogi2,387 participantsStarted Jun 2023

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Cullman, Alabama, United States +175 more locations

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Find Trials by Condition in Arizona

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

Hemodynamic-GUIDEd Management of Heart Failure

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Intranasal Oxytocin for the Treatment of Alcohol Use Disorder

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial